Blackstone to make $500m pharma investment(2)
Set to bolster its pharmaceuticals portfolio, Blackstone has agreed to make a $500 million minority investment in Florida-based Stiefel Laboratories.
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .Issues with signing in? Click here
Don't have an account? Register now
Set to bolster its pharmaceuticals portfolio, Blackstone has agreed to make a $500 million minority investment in Florida-based Stiefel Laboratories.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
Copyright PEI Media
Not for publication, email or dissemination